GlassScriptPhysician profile
Zafar Iqbal
NPI 1053571703
$3,169.03
in general payments reported to CMS, 2019-2025
29 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.13 · 2020: $51.98 · 2021: $177 · 2022: $818 · 2023: $1,163 · 2024: $537 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,007 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.53 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $395.93 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $282.07 | 2020-2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $252.15 | 2022-2025 | Jardiance |
| Cordis US Corp. | $238.92 | 2023-2025 | S.M.A.R.T., Brite Tip Radianz, Stabilizer |
| Cook Medical LLC | $233.74 | 2019-2023 | Zilver Vena |
| Pfizer INC. | $204.38 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $167.56 | 2021-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $166.25 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $156.51 | 2019-2024 | |
| Angiodynamics, INC. | $132.58 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.13 | 2019-2023 | Lifevest |
| Medtronic, INC. | $94.62 | 2023-2024 | Corevalve Evolut R, Venaseal |
| Inspire Medical Systems, INC. | $90.91 | 2023-2025 | Inspire |
| Kestra Medical Technology Services, INC. | $87.92 | 2022-2024 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $57.14 | 2021-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $50.65 | 2024 | Arcalyst |
| Philips North America LLC | $50.30 | 2022-2025 | Event |
| Esperion Therapeutics, INC. | $49.12 | 2022-2023 | Nexletol |
| Glaxosmithkline, LLC. | $48.10 | 2025 | Shingrix, Arexvy |
| Amgen INC. | $44.18 | 2019-2023 | Repatha |
| Abbott Laboratories | $38.07 | 2019-2021 | |
| Edwards Lifesciences Corporation | $37.88 | 2021-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bard Peripheral Vascular, INC. | $33.94 | 2023-2025 | Venclose Maven Catheter |
| Cvrx, INC. | $32.33 | 2022-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $31.04 | 2024 | Wainua, Farxiga |
| Actelion Pharmaceuticals US, INC. | $23.34 | 2023 | Uptravi, Opsumit |
| Cardiovascular Systems INC. | $19.07 | 2019-2022 | |
| Infobionic, INC | $17.83 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zafar Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.